![glp-1 gip mechanism of action & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) glp-1_analogs [TUSOM | Pharmwiki]](https://i.ytimg.com/vi/fWdhhzhvPkI/sddefault.jpg)
glp-1 gip mechanism of action & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) glp-1_analogs [TUSOM | Pharmwiki]
Description
But the initial rollout may not be smooth
![glp-1 gip mechanism of action & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
BMC Cancer
![glp-1 gip mechanism of action & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) glp-1_analogs [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S0196978122000158-gr4.jpg)
Yamanaka, M
![glp-1 gip mechanism of action & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) glp-1_analogs [TUSOM | Pharmwiki]](https://www.metabolismjournal.com/cms/10.1016/j.metabol.2020.154415/asset/b9663750-b529-4036-a400-8de00e106506/main.assets/gr1_lrg.jpg)
Wickens, University of WisconsinMadison)
![glp-1 gip mechanism of action & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41574-022-00783-3/MediaObjects/41574_2022_783_Fig2_HTML.png)
Other states are coming to that conclusion, as well as some private carriers. Overall Medicaid spending on GLP-1 drugs before partial rebates from drug manufacturers jumped from $577.3 million in 2019 to $3.9 billion in 2023, according to a November report from KFF, a nonprofit that researches health care issues
![glp-1 gip mechanism of action & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) glp-1_analogs [TUSOM | Pharmwiki]](https://i.ytimg.com/vi/9M9PQQXqdF8/maxresdefault.jpg)
